Beta-Thal. | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  131920 of 132336  at  8/14/2019 2:05:13 PM  by

marcbull99

The following message was updated on 8/14/2019 2:08:48 PM.

 In response to msg 131913 by  TECH32
view thread

Re: Beta-Thal.

  
 The CNS opportunities seem just much better than we ever have heard before and they are working om MS and Crohn´s disease as a follow up on the Tregs. All look good.
 
But I do share some concern for Beta Thal. This is the third conference call where Sandy is telling us it will take up to a year to really got results from Beta -Thal, comparing it to BLUE. Well, that surely is in contrast to the upbeat results from April 2 where we showed  over 30 %  levels after just some 8-10 weeks. No talk about that anymore. Not sure that it matters but it draws some parallels to MPS when they realized they will not show the great results their first data release promised. I just see a red flag, I could be totally wrong , but  I won´t  ignore those red flags anymore.  
 
Everything else, expecially CNS and Treg just sounded too good to be true. 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 281
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
131923 Re: Beta-Thal. NewJeans 11 8/14/2019 2:12:43 PM
131924 Re: Beta-Thal. TECH32 0 8/14/2019 2:13:23 PM
131925 Re: Beta-Thal. kvvvfb 1 8/14/2019 2:14:28 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...